Abstract
In this work, a novel “signal-on” electrochemical peptide biosensor based on peptide-conjugated hemin/G-quadruplex (DNAzyme-peptide) hybrid and rosebud-like MoSe2@reduced graphene oxide (MoSe2@rGO) nanocomposite, was developed for detection of prostate-specific antigen (PSA). Interestingly, the peptide not only served as recognition probe to detect PSA, but also acted as the enhancer to improve the enzyme activity of hemin/G4, which promoted the detection sensitivity. Up addition of PSA, Fe3O4-labeled DNAzyme-peptide probe was cleaved, followed by the magnetic separation. The cleaved DNAzyme-peptide was then captured onto the cysteine-modified electrode via the interaction between carboxyl groups of peptide and amino group of cysteine. A strong electrochemical signal was obtained from hemin and further was amplified by the enhanced electrocatalysis of DNAzyme-peptide. Compared to the original DNAzyme, DNAzyme-peptide exhibited more than 3-fold enhancement in signal amplification. And MoSe2@rGO amplified the electrochemical signal due to its good conductivity and large surface area. So the proposed strategy detected PSA down to 0.3 fg/mL, and it showed the advantages of simplicity, low cost by avoiding the use of expensive protein enzyme and additional electroactive species. Therefore, the proposed biosensor potentially provided a very effective tool for early diagnosis of cancer by the detection of PSA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.